incretins and Constriction--Pathologic

incretins has been researched along with Constriction--Pathologic* in 1 studies

Other Studies

1 other study(ies) available for incretins and Constriction--Pathologic

Article	Year
Potential mechanisms underlying differences in the effect of incretin-based antidiabetic drugs on the risk of major atherosclerotic ischemic events. Journal of diabetes and its complications, 2018, Volume: 32, Issue:6 Topics: Atherosclerosis; Constriction, Pathologic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incidence; Incretins; Ischemia; Myocardial Infarction; Risk Factors; Signal Transduction; Stroke	2018

Article

Year

Potential mechanisms underlying differences in the effect of incretin-based antidiabetic drugs on the risk of major atherosclerotic ischemic events.

Journal of diabetes and its complications, 2018, Volume: 32, Issue:6

Topics: Atherosclerosis; Constriction, Pathologic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incidence; Incretins; Ischemia; Myocardial Infarction; Risk Factors; Signal Transduction; Stroke

2018